Tissue destruction and invasion by Entamoeba histolytica

Trends in Parasitology

Volumn 27, Issue 6, 2011, Pages 254-263

  Ralston, Katherine S ^a   Petri, William A ^a  

^a UNIVERSITY OF VIRGINIA HEALTH SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYSTEINE PROTEINASE; MEMBRANE PROTEIN; SPHINGOLIPID ACTIVATOR PROTEIN;

AMEBIASIS; APOPTOSIS; CALCIUM TRANSPORT; CELL ADHESION; CELL INVASION; CELL MOTILITY; CHEMOTAXIS; CYTOTOXICITY; ENTAMOEBA HISTOLYTICA; ENVIRONMENTAL FACTOR; FOOD AVAILABILITY; GENETIC ANALYSIS; HOST PARASITE INTERACTION; HUMAN; HUMAN GENETICS; IMMUNE RESPONSE; MICROBIOME; NONHUMAN; NUTRITIONAL STATUS; PROTEIN DEPHOSPHORYLATION; REVIEW;

APOPTOSIS; CELL MOVEMENT; CHEMOTAXIS; CYSTEINE PROTEASES; CYTOTOXICITY, IMMUNOLOGIC; DYSENTERY, AMEBIC; ENTAMOEBA HISTOLYTICA; ENTAMOEBIASIS; HOST-PARASITE INTERACTIONS; HUMANS; IMMUNITY, INNATE; ION CHANNELS; LIVER ABSCESS, AMEBIC; PHOSPHORYLATION; PROTOZOAN PROTEINS; RECEPTORS, LEPTIN;

ENTAMOEBA HISTOLYTICA;

EID: 79956368200     PISSN: 14714922     EISSN: 14715007     Source Type: Journal    
DOI: 10.1016/j.pt.2011.02.006     Document Type: Review

References (90)

1. WHO WHO/PAHO/UNESCO report. A consultation with experts on amoebiasis. Mexico City, Mexico 28-29 January, 1997. Epidemiol. Bull. 1997, 18:13-14.
2. Mondal D., et al. Entamoeba histolytica-associated diarrheal illness is negatively associated with the growth of preschool children: evidence from a prospective study. Trans. R. Soc. Trop. Med. Hyg. 2006, 100:1032-1038.
3. Petri W.A., et al. The bittersweet interface of parasite and host: lectin-carbohydrate interactions during human invasion by the parasite Entamoeba histolytica. Annu. Rev. Microbiol. 2002, 56:39-64.
4. Petri W.A. Therapy of intestinal protozoa. Trends Parasitol. 2003, 19:523-526.
5. Pritt B.S., Clark C.G. Amebiasis. Mayo Clin. Proc. 2008, 83:1154-1159. quiz 1159-1160.
6. Ali I.K., et al. Entamoeba moshkovskii infections in children, Bangladesh. Emerg. Infect. Dis. 2003, 9:580-584.
7. Tanyuksel M., et al. Two cases of rarely recognized infection with Entamoeba moshkovskii. Am. J. Trop. Med. Hyg. 2007, 76:723-724.
8. Prathap K., Gilman R. The histopathology of acute intestinal amebiasis A rectal biopsy study. Am. J. Pathol. 1970, 60:229-246.
9. Maltz G., Knauer C.M. Amebic liver abscess: a 15-year experience. Am. J. Gastroenterol. 1991, 86:704-710.
10. Haque R., et al. Amebiasis. N. Engl. J. Med. 2003, 348:1565-1573.
11. Haque R., et al. Entamoeba histolytica infection in children and protection from subsequent amebiasis. Infect. Immun. 2006, 74:904-909.
12. Duggal P., et al. A mutation in the leptin receptor is associated with Entamoeba histolytica infection in children. J. Clin. Invest. 2011, 121:1191-1198.
13. Guo, X. et al. Leptin signaling in intestinal epithelium mediates resistance to enteric infection by Entamoeba histolytica. Mucosal Immunol. (in press) doi:10.1038/mi.2010.76.
14. Duggal P., et al. Influence of human leukocyte antigen class II alleles on susceptibility to Entamoeba histolytica infection in Bangladeshi children. J. Infect. Dis. 2004, 189:520-526.
15. Lotter H., et al. Sexual dimorphism in the control of amebic liver abscess in a mouse model of disease. Infect. Immun. 2006, 74:118-124.
16. Snow M., et al. Differences in complement-mediated killing of Entamoeba histolytica between men and women--an explanation for the increased susceptibility of men to invasive amebiasis?. Am. J. Trop. Med. Hyg. 2008, 78:922-923.
17. Ali I.K., et al. Evidence for a link between parasite genotype and outcome of infection with Entamoeba histolytica. J. Clin. Microbiol. 2007, 45:285-289.
18. Ali I.K., et al. Tissue invasion by Entamoeba histolytica: evidence of geneticselection and/or DNA reorganization events in organ tropism. PLoS Negl. Trop. Dis. 2008, 2:e219.
19. Valenzuela O., et al. Two different chitinase genotypes in a patient with an amebic liver abscess: a case report. Am. J. Trop. Med. Hyg. 2009, 80:51-54.
20. Loftus B., et al. The genome of the protist parasite Entamoeba histolytica. Nature 2005, 433:865-868.
21. Aurrecoechea C., et al. AmoebaDB and MicrosporidiaDB: functional genomic resources for Amoebozoa and Microsporidia species. Nucleic Acids Res. 2010, 10.1093/nar/gkq1006.
22. Bhattacharya A., et al. Molecular changes in Entamoeba histolytica in response to bacteria. J. Eukaryot. Microbiol. 1998, 45:28S-33S.
23. Galvan-Moroyoqui J.M., et al. The interplay between Entamoeba and enteropathogenic bacteria modulates epithelial cell damage. PLoS Negl. Trop. Dis. 2008, 2:e266.
24. Ravdin J.I., et al. Cytopathogenic mechanisms of Entamoeba histolytica. J. Exp. Med. 1980, 152:377-390.
25. Ravdin J.I., Guerrant R.L. Role of adherence in cytopathogenic mechanisms of Entamoeba histolytica Study with mammalian tissue culture cells and human erythrocytes. J. Clin. Invest. 1981, 68:1305-1313.
26. Ankri S., et al. Antisense inhibition of expression of the light subunit (35 kDa) of the Gal/GalNac lectin complex inhibits Entamoeba histolytica virulence. Mol. Microbiol. 1999, 33:327-337.
27. Sengupta K., et al. Physical, structural, and functional properties of the beta1 integrin-like fibronectin receptor (beta1EhFNR) in Entamoeba histolytica. Infect. Genet. Evol. 2009, 9:962-970.
28. Ravdin J.I., et al. Characterization of cell surface carbohydrate receptors for Entamoeba histolytica adherence lectin. Infect. Immun. 1989, 57:2179-2186.
29. Leroy A., et al. Contact-dependent transfer of the galactose-specific lectin of Entamoeba histolytica to the lateral surface of enterocytes in culture. Infect. Immun. 1995, 63:4253-4260.
30. Saffer L.D., Petri W.A. Role of the galactose lectin of Entamoeba histolytica in adherence-dependent killing of mammalian cells. Infect. Immun. 1991, 59:4681-4683.
31. Ravdin J.I., et al. Effect of antagonists of calcium and phospholipase A on the cytopathogenicity of Entamoeba histolytica. J. Infect. Dis. 1985, 152:542-549.
32. Ravdin J.I., et al. Effect of ion channel inhibitors on the cytopathogenicity of Entamoeba histolytica. J. Infect. Dis. 1982, 146:335-340.
33. Ravdin J.I., et al. Relationship of free intracellular calcium to the cytolytic activity of Entamoeba histolytica. Infect. Immun. 1988, 56:1505-1512.
34. Long-Krug S.A., et al. Phospholipase A enzymes of Entamoeba histolytica: description and subcellular localization. J. Infect. Dis. 1985, 152:536-541.
35. Gilchrist C.A., et al. Regulation of virulence of Entamoeba histolytica by the URE3-BP transcription factor. MBio 2010, 1.
36. Teixeira J.E., Mann B.J. Entamoeba histolytica-induced dephosphorylation in host cells. Infect. Immun. 2002, 70:1816-1823.
37. Kim K.A., et al. Calpain-dependent calpastatin cleavage regulates caspase-3 activation during apoptosis of Jurkat T cells induced by Entamoeba histolytica. Int. J. Parasitol. 2007, 37:1209-1219.
38. Kim K.A., et al. Calpain-dependent cleavage of SHP-1 and SHP-2 is involved in the dephosphorylation of Jurkat T cells induced by Entamoeba histolytica. Parasite Immunol. 2010, 32:176-183.
39. Berninghausen O., Leippe M. Necrosis versus apoptosis as the mechanism of target cell death induced by Entamoeba histolytica. Infect. Immun. 1997, 65:3615-3621.
40. Ragland B.D., et al. Entamoeba histolytica: target cells killed by trophozoites undergo DNA fragmentation which is not blocked by Bcl-2. Exp. Parasitol. 1994, 79:460-467.
41. Huston C.D., et al. Caspase 3-dependent killing of host cells by the parasite Entamoeba histolytica. Cell. Microbiol. 2000, 2:617-625.
42. Seydel K.B., Stanley S.L. Entamoeba histolytica induces host cell death in amebic liver abscess by a non-Fas-dependent, non-tumor necrosis factor alpha-dependent pathway of apoptosis. Infect. Immun. 1998, 66:2980-2983.
43. Yan L., Stanley S.L. Blockade of caspases inhibits amebic liver abscess formation in a mouse model of disease. Infect. Immun. 2001, 69:7911-7914.
44. Becker S.M., et al. Epithelial cell apoptosis facilitates Entamoeba histolytica infection in the gut. Am. J. Pathol. 2010, 176:1316-1322.
45. Andra J., et al. Amoebapores, archaic effector peptides of protozoan origin, are discharged into phagosomes and kill bacteria by permeabilizing their membranes. Dev. Comp. Immunol. 2003, 27:291-304.
46. Hecht O., et al. Solution structure of the pore-forming protein of Entamoeba histolytica. J. Biol. Chem. 2004, 279:17834-17841.
47. Leippe M., et al. Cytolytic and antibacterial activity of synthetic peptides derived from amoebapore, the pore-forming peptide of Entamoeba histolytica. Proc. Natl. Acad. Sci. U.S.A. 1994, 91:2602-2606.
48. Bracha R., et al. Transcriptional silencing of multiple genes in trophozoites of Entamoeba histolytica. PLoS Pathog. 2006, 2:e48.
49. Bracha R., et al. Antisense inhibition of amoebapore expression in Entamoeba histolytica causes a decrease in amoebic virulence. Mol. Microbiol. 1999, 34:463-472.
50. Bracha R., et al. Transcriptional silencing of an amoebapore gene in Entamoeba histolytica: molecular analysis and effect on pathogenicity. Eukaryot. Cell 2003, 2:295-305.
51. Bujanover S., et al. A virulence attenuated amoebapore-less mutant of Entamoeba histolytica and its interaction with host cells. Int. J. Parasitol. 2003, 33:1655-1663.
52. Zhang X., et al. Expression of amoebapores is required for full expression of Entamoeba histolytica virulence in amebic liver abscess but is not necessary for the induction of inflammation or tissue damage in amebic colitis. Infect. Immun. 2004, 72:678-683.
53. Bruhn H., Leippe M. Novel putative saposin-like proteins of Entamoeba histolytica different from amoebapores. Biochim. Biophys. Acta 2001, 1514:14-20.
54. Winkelmann J., et al. A novel saposin-like protein of Entamoeba histolytica with membrane-fusogenic activity. Mol. Biochem. Parasitol. 2006, 147:85-94.
55. Keene W.E., et al. The major neutral proteinase of Entamoeba histolytica. J. Exp. Med. 1986, 163:536-549.
56. Lauwaet T., et al. Proteolysis of enteric cell villin by Entamoeba histolytica cysteine proteinases. J. Biol. Chem. 2003, 278:22650-22656.
57. Li E., et al. Interaction of laminin with Entamoeba histolytica cysteine proteinases and its effect on amebic pathogenesis. Infect. Immun. 1995, 63:4150-4153.
58. Lidell M.E., et al. Entamoeba histolytica cysteine proteases cleave the MUC2 mucin in its C-terminal domain and dissolve the protective colonic mucus gel. Proc. Natl. Acad. Sci. U.S.A. 2006, 103:9298-9303.
59. Luaces A.L., Barrett A.J. Affinity purification and biochemical characterization of histolysin, the major cysteine proteinase of Entamoeba histolytica. Biochem. J. 1988, 250:903-909.
60. Hellberg A., et al. Overexpression of cysteine proteinase 2 in Entamoeba histolytica or Entamoeba dispar increases amoeba-induced monolayer destruction in vitro but does not augment amoebic liver abscess formation in gerbils. Cell. Microbiol. 2001, 3:13-20.
61. Mitra B.N., et al. Rab11B small GTPase regulates secretion of cysteine proteases in the enteric protozoan parasite Entamoeba histolytica. Cell. Microbiol. 2007, 9:2112-2125.
62. Tillack M., et al. Increased expression of the major cysteine proteinases by stable episomal transfection underlines the important role of EhCP5 for the pathogenicity of Entamoeba histolytica. Mol. Biochem. Parasitol. 2006, 149:58-64.
63. Sen A., et al. The 29-kilodalton thiol-dependent peroxidase of Entamoeba histolytica is a factor involved in pathogenesis and survival of the parasite during oxidative stress. Eukaryot. Cell 2007, 6:664-673.
64. MacFarlane R.C., Singh U. Identification of an Entamoeba histolytica serine-, threonine-, and isoleucine-rich protein with roles in adhesion and cytotoxicity. Eukaryot. Cell 2007, 6:2139-2146.
65. Shrimal S., et al. Serum-dependent selective expression of EhTMKB1-9, a member of Entamoeba histolytica B1 family of transmembrane kinases. PLoS Pathog. 2010, 6:e1000929.
66. Santi-Rocca J., et al. The lysine- and glutamic acid-rich protein KERP1 plays a role in Entamoeba histolytica liver abscess pathogenesis. Cell. Microbiol. 2008, 10:202-217.
67. Seigneur M., et al. A lysine- and glutamic acid-rich protein KERP1, from Entamoeba histolytica binds to human enterocytes. Cell. Microbiol. 2005, 7:569-579.
68. Ravdin J.I., et al. Acid intracellular vesicles and the cytolysis of mammalian target cells by Entamoeba histolytica trophozoites. J. Protozool. 1986, 33:478-486.
69. Maugis B., et al. Dynamic instability of the intracellular pressure drives bleb-based motility. J. Cell Sci. 2010, 123:3884-3892.
70. Zaki M., et al. Entamoeba histolytica cell movement: a central role for self-generated chemokines and chemorepellents. Proc. Natl. Acad. Sci. U.S.A. 2006, 103:18751-18756.
71. Blazquez S., et al. Human tumor necrosis factor is a chemoattractant for the parasite Entamoeba histolytica. Infect. Immun. 2006, 74:1407-1411.
72. Tillack M., et al. The Entamoeba histolytica genome: primary structure and expression of proteolytic enzymes. BMC Genomics 2007, 8:170.
73. Reed S.L., et al. Thiol proteinase expression and pathogenicity of Entamoeba histolytica. J. Clin. Microbiol. 1989, 27:2772-2777.
74. Ankri S., et al. Antisense inhibition of expression of cysteine proteinases affects Entamoeba histolytica-induced formation of liver abscess in hamsters. Infect. Immun. 1999, 67:421-422.
75. Stanley S.L., et al. Role of the Entamoeba histolytica cysteine proteinase in amebic liver abscess formation in severe combined immunodeficient mice. Infect. Immun. 1995, 63:1587-1590.
76. Zhang Z., et al. Entamoeba histolytica cysteine proteinases with interleukin-1 beta converting enzyme (ICE) activity cause intestinal inflammation and tissue damage in amoebiasis. Mol. Microbiol. 2000, 37:542-548.
77. He C., et al. A novel Entamoeba histolytica cysteine proteinase EhCP4, is key for invasive amebiasis and a therapeutic target. J. Biol. Chem. 2010, 285:18516-18527.
78. Melendez-Lopez S.G., et al. Use of recombinant Entamoeba histolytica cysteine proteinase 1 to identify a potent inhibitor of amebic invasion in a human colonic model. Eukaryot. Cell 2007, 6:1130-1136.
79. Eckmann L., et al. Entamoeba histolytica trophozoites induce an inflammatory cytokine response by cultured human cells through the paracrine action of cytolytically released interleukin-1 alpha. J. Clin. Invest. 1995, 96:1269-1279.
80. Seydel K.B., et al. Human intestinal epithelial cells produce proinflammatory cytokines in response to infection in a SCID mouse-human intestinal xenograft model of amebiasis. Infect. Immun. 1997, 65:1631-1639.
81. Reed S.L., et al. The extracellular neutral cysteine proteinase of Entamoeba histolytica degrades anaphylatoxins C3a and C5a. J. Immunol. 1995, 155:266-274.
82. Hou Y., et al. Entamoeba histolytica cysteine proteinase 5 binds integrin on colonic cells and stimulates NF{kappa}B-mediated pro-inflammatory responses. J. Biol. Chem. 2010, 285:35497-35504.
83. Stanley S.L. Amoebiasis. Lancet 2003, 361:1025-1034.
84. Houpt E.R., et al. The mouse model of amebic colitis reveals mouse strain susceptibility to infection and exacerbation of disease by CD4+ T cells. J. Immunol. 2002, 169:4496-4503.
85. Bansal D., et al. An ex-vivo human intestinal model to study Entamoeba histolytica pathogenesis. PLoS Negl. Trop. Dis. 2009, 3:e551.
86. Carranza-Rosales P., et al. Precision-cut hamster liver slices as an ex vivo model to study amoebic liver abscess. Exp. Parasitol. 2010, 126:117-125.
87. Ramakrishnan G., et al. A tetracycline-inducible gene expression system in Entamoeba histolytica. Mol. Biochem. Parasitol. 1997, 84:93-100.
88. Linford A.S., et al. Short hairpin RNA-mediated knockdown of protein expression in Entamoeba histolytica. BMC Microbiol. 2009, 9:38.
89. Solis C.F., et al. Use of bacterially expressed dsRNA to downregulate Entamoeba histolytica gene expression. PLoS ONE 2009, 4:e8424.
90. Zhang H., et al. Small RNAs with 5'-polyphosphate termini associate with a Piwi-related protein and regulate gene expression in the single-celled eukaryote Entamoeba histolytica. PLoS Pathog. 2008, 4:e1000219.